14th annual PEGS Europe - Sara Majocchi -
Light Chain Bioscience is very pleased to have Sara Majocchi speaking at the 14th Annual PEGS Europe Summit, the largest protein & antibody engineering event in Europe.
Sara will talk about “Costimulatory CD28 Bispecific Antibodies for Tumor-Targeted T Cell Activation” as part of the bispecifics stream on Tuesday, November 15 @ 17:30 CET.
Tumor-targeted CD28 bispecific antibodies (bsAbs) are designed to co-stimulate T cells specifically within the tumor microenvironment. By bridging T cells to malignant cells expressing a selected tumor-associated antigen (TAA), CD28 bsAbs deliver signal 2 to T cells, unleashing their full cytotoxic potential. Using our κλ body antibody platform, an array of TAA-CD28 κλ bodies was generated and their capacity to provide signal 2 to T cells was assessed in vitro and in vivo.
14-16 november 2022
InterContinental Barcelona
